相关实验视频
Updated: Jun 5, 2025

07:34
FISH for Pre-implantation Genetic Diagnosis
Published on: February 23, 2011
36.7K
多基因风险评分和胚胎查:对监管的考虑
Casey M Haining1, Julian Savulescu2,3, Louise Keogh1
1Centre for Health Equity, Melbourne School of Population and Global Health, The University of Melbourne, Melbourne, Victoria, Australia.
Journal of medical ethics
|December 16, 2024
概括
多基因风险评分 (PRS) 可以为胚胎查的生殖选择提供信息,但这一做法仍在争论中. 本文探讨了在生殖决策中使用PRS的伦理问题和监管需求.
科学领域:
- 生殖遗传学 生殖遗传学
- 生物伦理学生物伦理学
- 基因查是一种基因查.
背景情况:
- 多基因风险评分 (PRS) 越来越多地被讨论用于生殖决策.
- 它们在胚胎查中的应用提出了新的伦理和监管挑战.
- 目前的使用是有限的,但正在增长,需要仔细考虑.
研究的目的:
- 提供与使用PRS在胚胎查中的伦理考虑的概述.
- 为考虑在生殖环境中使用PRS的司法管辖区提出监管考虑.
- 解决持续技术和研究改进的需要.
主要方法:
- 在生殖遗传学中PRS应用的伦理分析.
- 对基因查技术的潜在监管框架的审查.
- 确定未来监管的关键组成部分.
主要成果:
- 在使用PRS进行胚胎查时,出现了重要的伦理考虑.
- 为了负责任的实施,需要一个全面的监管框架.
- 关键的监管要素包括明确的资格,教育和监督.
结论:
- 在胚胎查中使用PRS需要仔细的伦理审议和强有力的监管监督.
- 未来的法规必须解决技术进步,公众教育和持续的咨询问题.
- 积极的监管规划对于在生殖决策中应对PRS的复杂性至关重要.
相关概念视频
Genetic Screens
4.9K
Genetic screens are tools used to identify genes and mutations responsible for phenotypes of interest. Genetic screens help identify individuals or a group of people at risk of developing genetic diseases and help them with early intervention, targeted therapy, and reproductive options.
Forward genetic screens
Forward or “classical” genetic screens involve creating random mutations in an organism’s DNA using radiation, mutagens, or insertion of additional bases, which...
Forward genetic screens
Forward or “classical” genetic screens involve creating random mutations in an organism’s DNA using radiation, mutagens, or insertion of additional bases, which...
4.9K
CRISPR
49.3K
Genome editing technologies allow scientists to modify an organism’s DNA via the addition, removal, or rearrangement of genetic material at specific genomic locations. These types of techniques could potentially be used to cure genetic disorders such as hemophilia and sickle cell anemia. One popular and widely used DNA-editing research tool that could lead to safe and effective cures for genetic disorders is the CRISPR-Cas9 system. CRISPR-Cas9 stands for Clustered Regularly Interspaced...
49.3K
Embryonic Stem Cells
3.4K
Embryonic stem (ES) cells were first discovered in mice in 1981 by Martin Evans. In 1998, James Thomson identified a method to isolate embryonic stem cells from humans. Human embryonic stem cells (hESCs) are obtained from 3-5 day old embryos that remain unused after an in vitro fertilization procedure.
ES cells are grown in a culture medium where they can divide indefinitely, creating ES cell lines. Under certain conditions, ES cells can differentiate, either spontaneously into a variety of...
ES cells are grown in a culture medium where they can divide indefinitely, creating ES cell lines. Under certain conditions, ES cells can differentiate, either spontaneously into a variety of...
3.4K
Teratogenicity
2.3K
The ability of a drug to produce structural deformations and functional abnormalities in the developing embryo or the fetus is called teratogenicity, and the drug producing this effect is known as a teratogen. Teratogenic effects include stillbirth, miscarriage, intrauterine growth restriction, and neurocognitive delay. A teratogen may affect the embryo at different stages of development, which is important in determining the type and extent of the damage. During blastocyst formation, the early...
2.3K
Genomic Imprinting and Inheritance
33.2K
Diploid organisms inherit genetic material through chromosomes from both parents. Copies of the same gene are known as alleles. In most cases, both alleles are simultaneously expressed and allow various cellular processes to function optimally. If one of the alleles is missing or mutated, the expression of the other allele can compensate; however, this is not true for all genes.
The expression of some genes depends on which parent passed the gene to the offspring, through a phenomenon known as...
The expression of some genes depends on which parent passed the gene to the offspring, through a phenomenon known as...
33.2K

